Service Line: Rapid Response Service Version: 1.0 Publication Date: January 25, 2017 Report Length: 5 Pages

Similar documents
Service Line: Rapid Response Service Version: 1.0 Publication Date: June 22, 2017 Report Length: 5 Pages

The Assessment of Postoperative Vital Signs: Clinical Effectiveness and Guidelines

Disposable, Non-Sterile Gloves for Minor Surgical Procedures: A Review of Clinical Evidence

TITLE: Double Gloves for Prevention of Transmission of Blood Borne Pathogens to Patients: A Review of the Clinical Evidence

Policy Forum Health Technology Policy Options Renal Replacement Therapy in Critical Care

TITLE: Pill Splitting: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines

University of Ottawa (uottawa) Terms & Non-Disclosure Agreement. for. Mitacs Accelerate Internships and. Mitacs Elevate Postdoctoral Fellowships

Health Technology Assessment and Optimal Use: Medical Devices; Diagnostic Tests; Medical, Surgical, and Dental Procedures

Title: Length of use guidelines for oxygen tubing and face mask equipment

KNOWLEDGE SYNTHESIS: Literature Searches and Beyond

Hand Antisepsis Procedures: A Review of Guidelines

Type of intervention Treatment. Economic study type Cost-effectiveness analysis.

Giant Tiger s Home for the Holidays Christmas Contest Official Rules

Robot-Assisted Surgeries A Project for CADTH, a Decision for Jurisdictions

Low Molecular Weight Heparins

Methodology Notes. Identifying Indicator Top Results and Trends for Regions/Facilities

NZWCS Venous Ulcer Clinical Pathway

TITLE: Eden Alternative and Green House Concept of Care: Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines

Our Terms of Use and other areas of our Sites provide guidelines ("Guidelines") and rules and regulations ("Rules") in connection with OUEBB.

Setting and Implementing Provincial Wound Care Quality Standards for Ontario

Recommendations for Adoption: Diabetic Foot Ulcer. Recommendations to enable widespread adoption of this quality standard

Technology Overview. Issue 13 August A Clinical and Economic Review of Telephone Triage Services and Survey of Canadian Call Centre Programs

Hain-Celestial Canada, ULC presents the Yves Veggie Cuisine SIZZING SUMMER FIRE UP YOUR GRILL Contest

Context. Objectives. Hospital-based Pharmacy and Therapeutics Committees: Evolving Responsibilities and Membership

Title: Automated External Defibrillators in Long-Term Care Facilities. Date: 24 September Context and Policy Issues:

Evaluation of a Telehealth Initiative in Wound Management. Margarita Loyola Interior Health

Are you at risk of blood clots?

Expression of Interest for Wound Care Project

The Winnipeg Regional Health Authority

RBC Show Arbie and WIN Student Photo Contest Official Rules and Regulations. Questions:

Turning for the Prevention and Management of Pressure Ulcers: OHTAC Recommendation

Nursing skill mix and staffing levels for safe patient care

M-COR Modular Hip System Surgical Technique Chart

Ohio Opioid Technology Challenge Idea Phase

SACRAL NERVE STIMULATION (NEUROMODULATION)

Also available from Huntleigh Healthcare. Patient Information: Pressure ulcers. Venous leg ulcer: A patient carer guide

Hostgator Scholarship Program. Official Rules

Wound Care Reimbursement. Things Are A-Changing!

#AcneFreeLife Sweepstakes Official Rules:

Clinical Development Process 2017

PCORI s Approach to Patient Centered Outcomes Research

REQUEST FOR PROPOSAL

Living Will Sample Massachusetts (aka "Advanced Medical Directive")

Essential Skills for Evidence-based Practice: Evidence Access Tools

SEATTLE ART MUSEUM #SummerAtSAM PHOTO CONTEST OFFICIAL RULES

Methodology Notes. Cost of a Standard Hospital Stay: Appendices to Indicator Library

INR Self Testing. Stephan Moll, MD Department of Medicine HEMOPHILIA AND THROMBOSIS CENTER UNIVERSITY OF NORTH CAROLINA

METHODOLOGY. Transparency. Conflicts of Interest. Multidisciplinary Steering Committee Composition. Evidence Review

INDIGENOUS DAY LIVE 2018 ROCK YOUR MOCS OFF CONTEST RULES AND REGULATIONS

Addendum to ICH E6 (R2)

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Shoulder program of care. reference guide OCTOBER 2012

SYSTEMATIC REVIEW METHODS. Unit 1

The Royal Wolverhampton NHS Trust

PUBLISHER Kensington Publishing/ WATTPAD WRITING CONTEST ( Writing Contest ) OFFICIAL RULES

PLEASE SCROLL DOWN FOR ARTICLE. Full terms and conditions of use:

An economic evaluation of compression therapy for venous leg ulcers

The RYOBI COMMIT2IT Contest. Official Rules

Win a Panda Trek in Nepal Contest Official Rules

2.3. Any amendment to the present "Terms and Conditions" will only be valid if approved, in writing, by the Agency.

N ATIONAL Q UALITY F ORUM. Safe Practices for Better Healthcare 2006 Update A CONSENSUS REPORT

Reuse of SUDs: Using Evidence to Inform Policy

The Rx for Change database: a first-in-class tool for optimal prescribing and medicines use

Mandatory Reporting A process

General Terms and Conditions

The Chevron-Marketer Miami-Dade Fuel Your School Promotion Miami-Dade County in Florida

emja: Measuring patient-reported outcomes: moving from clinical trials into clinical p...

DAVIDsTEA + ME to WE Contest OFFICIAL CONTEST RULES NO PURCHASE NECESSARY TO ENTER OR WIN. A PURCHASE WILL NOT INCREASE YOUR CHANCES OF WINNING.

Notre Dame College Website Terms of Use

Preoperative Consultations: OHTAC Recommendation

Rapid Review Evidence Summary: Manual Double Checking August 2017

Evidence-Based Practice Pulling the pieces together. Lynette Savage, RN, PhD, COI March 2017

Policies and Procedures. I.D. Number: 1038

Addendum 1 Compliance indicators for the Australian Privacy Principles

Outcome-Based Pathways Unilateral Total Hip Replacement And Unilateral Total Knee Replacement

RNAO International Affairs and Best Practice Guidelines Program

TOTAL KNEE REPLACEMENT BASKET OF CARE SUBCOMMITTEE Report to: Minnesota Department of Health. June 22, 2009

Efficacy of Tympanostomy Tubes for Children with Recurrent Acute Otitis Media Randomization Phase

JERSEY COLLEGE RECOGNITION OF 5000 TH GRADUATE SCHOLARSHIP PROGRAM RULES FOR PARTICIPATION AND AWARDING

A systematic review of the literature: executive summary

Objectives. Evidence Based Resources for Answering Clinical Questions: Only a Click Away. What is Evidence Based Practice?

New Patient Intake Form

Aboriginal Health Human. A Current Snapshot

Prevention and Treatment of Venous Thromboembolism (VTE) Policy

GENERAL CONSENT TO TREAT

Google Capture the Flag 2018 Official Rules

Neurocritical Care Rotation - EUH

Qatar University College of Pharmacy Advanced Clinical Internship WOMEN S HEALTH (OB/GYN)

Malnutrition Screening Pathway v.1.1

Hospital Events 2007/08

International Champions Cup Singapore Skills Challenge Contest Terms and Conditions

Preventing Blood Clots in Hospitals

Medical students and residents

Start-up business class

Rapid Response Report:

Health Technology Review Business Case Template

AMERICAN ORTHOPAEDIC SOCIETY FOR SPORTS MEDICINE SANDY KIRKLEY CLINICAL OUTCOMES RESEARCH GRANT

F686: Updates on Regulations for Pressure Ulcer/Injury Prevention and Care

Hospital data to improve the quality of care and patient safety in oncology

My Wishes for Future Health Care

Transcription:

CADTH RAPID RESPONSE REPORT: REFERENCE LIST Sequential Wave-Based Compression Calf Pumps for Patients in the Home-Care Setting: Clinical Effectiveness, Cost- Effectiveness, and Guidelines Service Line: Rapid Response Service Version: 1.0 Publication Date: January 25, 2017 Report Length: 5 Pages

Authors: Kristen Moulton, Charlene Argáez Cite As: Sequential Wave-Based Compression Calf Pumps for Patients in the Home-Care Setting: Clinical Effectiveness, Cost-Effectiveness, and Guidelines. Ottawa: CADTH; 2017 Jan. (CADTH rapid response report: reference list). Acknowledgments: Disclaimer: The information in this document is intended to help Canadian health care decision-makers, health care professionals, health systems leaders, and policy-makers make well-informed decisions and thereby improve the quality of health care services. While patients and others may access this document, the document is made available for informational purposes only and no representations or warranties are made with respect to its fitness for any particular purpose. The information in this document should not be used as a substitute for professional medical advice or as a substitute for the application of clinical judgment in respect of the care of a particular patient or other professional judgment in any decision-making process. The Canadian Agency for Drugs and Technologies in Health (CADTH) does not endorse any information, drugs, therapies, treatments, products, processes, or services. While care has been taken to ensure that the information prepared by CADTH in this document is accurate, complete, and up-to-date as at the applicable date the material was first published by CADTH, CADTH does not make any guarantees to that effect. CADTH does not guarantee and is not responsible for the quality, currency, propriety, accuracy, or reasonableness of any statements, information, or conclusions contained in any third-party materials used in preparing this document. The views and opinions of third parties published in this document do not necessarily state or reflect those of CADTH. CADTH is not responsible for any errors, omissions, injury, loss, or damage arising from or relating to the use (or misuse) of any information, statements, or conclusions contained in or implied by the contents of this document or any of the source materials. This document may contain links to third-party websites. CADTH does not have control over the content of such sites. Use of third-party sites is governed by the third-party website owners own terms and conditions set out for such sites. CADTH does not make any guarantee with respect to any information contained on such third-party sites and CADTH is not responsible for any injury, loss, or damage suffered as a result of using such third-party sites. CADTH has no responsibility for the collection, use, and disclosure of personal information by third-party sites. Subject to the aforementioned limitations, the views expressed herein are those of CADTH and do not necessarily represent the views of Canada s federal, provincial, or territorial governments or any third party supplier of information. This document is prepared and intended for use in the context of the Canadian health care system. The use of this document outside of Canada is done so at the user s own risk. This disclaimer and any questions or matters of any nature arising from or relating to the content or use (or misuse) of this document will be governed by and interpreted in accordance with the laws of the Province of Ontario and the laws of Canada applicable therein, and all proceedings shall be subject to the exclusive jurisdiction of the courts of the Province of Ontario, Canada. The copyright and other intellectual property rights in this document are owned by CADTH and its licensors. These rights are protected by the Canadian Copyright Act and other national and international laws and agreements. Users are permitted to make copies of this document for non-commercial purposes only, provided it is not modified when reproduced and appropriate credit is given to CADTH and its licensors. About CADTH: CADTH is an independent, not-for-profit organization responsible for providing Canada s health care decision-makers with objective evidence to help make informed decisions about the optimal use of drugs, medical devices, diagnostics, and procedures in our health care system. REFERENCE LIST Sequential Wave-Based Compression Calf Pumps for Patients in the Home-Care Setting 2

Research Questions 1. What is the clinical effectiveness of sequential wave-based compression calf pump devices for patients in the home-care setting? 2. What is the comparative clinical effectiveness of sequential wave-based compression calf pump devices for patients in the home-care setting? 3. What is the cost-effectiveness of sequential wave-based compression calf pump devices? 4. What are the evidence-based guidelines regarding the use of sequential wave-based compression calf pump devices in the home-care setting? Key Findings No relevant literature regarding the clinical effectiveness, comparative clinical effectiveness, or cost-effectiveness of sequential wave-based compression calf pump devices was identified. Additionally, no evidence based guidelines regarding the use of sequential wavebased compression calf pump devices in the home-care setting were identified. Methods A limited literature search was conducted on key resources including PubMed, The Cochrane Library, University of York Centre for Reviews and Dissemination (CRD) databases, Canadian and major international health technology agencies, as well as a focused Internet search. Methodological filters were applied to limit retrieval to health technology assessments, systematic reviews, meta-analyses, guidelines, economic studies, randomized controlled trials, and non-randomized studies. Where possible, retrieval was limited to the human population. The search was also limited to English language documents published between January 1, 2012, and January 17, 2017. Internet links were provided, where available. Selection Criteria One reviewer screened citations and selected studies based on the inclusion criteria presented in Table 1. Table 1: Selection Criteria Population Intervention Comparator Q1, 2 and 4: Patients of any age in the home-care setting Q3: Patients of any age Sequential compression calf pumps delivering wave-form motion stimulation (e.g., BIOS Living Compression Pump, Venowave) Q1 and 3: No intervention or usual care (with no compression intervention); Q2 and 3: Disposable neuromuscular electrostimulation devices (e.g., Geko device); Compression stockings; Intermittent pneumatic compression devices (e.g., Kendall SCD, VenaFlow, PlexiPulse, A-V Impulse System); Leg elevation and other physical therapies; Pharmacotherapy (e.g., diuretics, aspirin, anticoagulation, pentoxifylline, prostacyclins, zinc sulfate); Invasive surgical or endovascular procedures (e.g., sclerotherapy, ablation, phlebectomy, venous REFERENCE LIST Sequential Wave-Based Compression Calf Pumps for Patients in the Home-Care Setting 3

Table 1: Selection Criteria Outcomes Study Designs ligation or excision) Q4: No comparator Q1 and 2: Clinical effectiveness (e.g., venous thromboembolism risk, major bleeding, changes in standardized symptom scores (e.g., CEAP classification, AVVQ score, Venous Clinical Severity Score), lower extremity edema, lower extremity pain, quality of life, lower extremity venous hemodynamics, venous wound healing, recurrent ulceration, repeat intervention, lower extremity amputation); Harms (e.g., bleeding, venous wound infection, thrombophlebitis, venous thrombosis, venous thromboembolic events, death) Q3: Cost-effectiveness outcomes (e.g., cost per quality adjusted life year or clinical benefit); Q4: Evidence-based guideline recommendations regarding the use of the intervention in the home-care setting Health technology assessments, systematic reviews, meta-analyses, randomized controlled trials, nonrandomized studies, economic evaluations, evidence-based guidelines Results No relevant health technology assessments, systematic reviews, meta-analyses, randomized controlled trials, or non-randomized studies were identified regarding the clinical or comparative clinical effectiveness or guidelines for the use of sequential wavebased compression calf pump devices for patients in the home-care setting were identified. Additionally, no relevant economic evaluations were identified. References of potential interest are provided in the appendix. Health Technology Assessments Systematic Reviews and Meta-analyses Randomized Controlled Trials Non-Randomized Studies Economic Evaluations Guidelines and Recommendations REFERENCE LIST Sequential Wave-Based Compression Calf Pumps for Patients in the Home-Care Setting 4

Appendix Further Information Randomized Controlled Trials Hospitalized Patients 1. Sobieraj-Teague M, Hirsh J, Yip G, Gastaldo F, Stokes T, Sloane D, et al. Randomized controlled trial of a new portable calf compression device (Venowave) for prevention of venous thrombosis in high-risk neurosurgical patients. J Thromb Haemost. 2012 Feb;10(2):229-35. PubMed: PM22188037 Additional References 2. Keijsers JM, Leguy CA, Huberts W, Narracott AJ, Rittweger J, van de Vosse FN. A 1D pulse wave propagation model of the hemodynamics of calf muscle pump function. Int J Numer Method Biomed Eng [Internet]. 2015 Jul[cited 2017 Jan 24];31(7):e02716. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/pmc4676919pubmed: PM25766693 REFERENCE LIST Sequential Wave-Based Compression Calf Pumps for Patients in the Home-Care Setting 5